BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 33582320)

  • 21. Prevalence of liver injury and correlation with clinical outcomes in patients with COVID-19: systematic review with meta-analysis.
    Del Zompo F; De Siena M; Ianiro G; Gasbarrini A; Pompili M; Ponziani FR
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):13072-13088. PubMed ID: 33378061
    [TBL] [Abstract][Full Text] [Related]  

  • 22. REPLY TO: Interleukin-17: a potential therapeutic target in COVID-19.
    Piaserico S; Meneguzzo A; Messina F
    J Infect; 2020 Sep; 81(3):e37-e38. PubMed ID: 32610110
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical characteristics of COVID-19 patients with hepatitis B virus infection - a retrospective study.
    Liu R; Zhao L; Cheng X; Han H; Li C; Li D; Liu A; Gao G; Zhou F; Liu F; Jiang Y; Zhu C; Xia Y
    Liver Int; 2021 Apr; 41(4):720-730. PubMed ID: 33351265
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SARS-CoV-2 infection and viral load are associated with the upper respiratory tract microbiome.
    Rosas-Salazar C; Kimura KS; Shilts MH; Strickland BA; Freeman MH; Wessinger BC; Gupta V; Brown HM; Rajagopala SV; Turner JH; Das SR
    J Allergy Clin Immunol; 2021 Apr; 147(4):1226-1233.e2. PubMed ID: 33577896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [CME Rheumatology 23: Rheumatoid Arthritis Following COVID-19/SARS-CoV-2 Infection].
    Tamborrini G; Micheroli R
    Praxis (Bern 1994); 2021 Apr; 110(6):293-297. PubMed ID: 33906448
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reply to: "COVID-19-associated liver injury (COVALI): role of hepatologists".
    Li D; Ding X; Tian D; Xia L
    J Gastroenterol; 2021 Aug; 56(8):788-789. PubMed ID: 34251568
    [No Abstract]   [Full Text] [Related]  

  • 27. Reactivation of SARS-CoV-2 infection following recovery from COVID-19.
    Chen Z; Xie W; Ge Z; Wang Y; Zhao H; Wang J; Xu Y; Zhang W; Song M; Cui S; Wang X; Pan CQ
    J Infect Public Health; 2021 May; 14(5):620-627. PubMed ID: 33848891
    [TBL] [Abstract][Full Text] [Related]  

  • 28. No detection of SARS-CoV-2 in cystic fibrosis patients at the Regional (Lazio) Reference Center for CF in Italy.
    Scagnolari C; Bitossi C; Frasca F; Viscido A; Oliveto G; Scordio M; De Vito C; Trancassini M; Midulla F; Cimino G; Pierangeli A; Antonelli G
    J Cyst Fibros; 2020 Sep; 19(5):837-838. PubMed ID: 32593510
    [No Abstract]   [Full Text] [Related]  

  • 29. High prevalence of SARS-CoV-2 infection among symptomatic healthcare workers in a large university tertiary hospital in São Paulo, Brazil.
    Buonafine CP; Paiatto BNM; Leal FB; de Matos SF; de Morais CO; Guerra GG; Martuchelli MVV; Oliveira DBL; Durigon EL; Soares CP; Candido ED; Telezynski BL; Sáfadi MAP; Almeida FJ
    BMC Infect Dis; 2020 Dec; 20(1):917. PubMed ID: 33267836
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liver fibrosis and adverse outcomes in COVID-19.
    Huang J
    Dig Liver Dis; 2021 Jul; 53(7):799. PubMed ID: 33994131
    [No Abstract]   [Full Text] [Related]  

  • 31. Outcomes of Neonates Born to Mothers With Severe Acute Respiratory Syndrome Coronavirus 2 Infection at a Large Medical Center in New York City.
    Dumitriu D; Emeruwa UN; Hanft E; Liao GV; Ludwig E; Walzer L; Arditi B; Saslaw M; Andrikopoulou M; Scripps T; Baptiste C; Khan A; Breslin N; Rubenstein D; Simpson LL; Kyle MH; Friedman AM; Hirsch DS; Miller RS; Fernández CR; Fuchs KM; Keown MK; Glassman ME; Stephens A; Gupta A; Sultan S; Sibblies C; Whittier S; Abreu W; Akita F; Penn A; D'Alton ME; Orange JS; Goffman D; Saiman L; Stockwell MS; Gyamfi-Bannerman C
    JAMA Pediatr; 2021 Feb; 175(2):157-167. PubMed ID: 33044493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association Between ABO and Rh Blood Groups and SARS-CoV-2 Infection or Severe COVID-19 Illness : A Population-Based Cohort Study.
    Ray JG; Schull MJ; Vermeulen MJ; Park AL
    Ann Intern Med; 2021 Mar; 174(3):308-315. PubMed ID: 33226859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [COVID-toes, a cutaneous sign of innate resistance to SARS-CoV-2].
    Yatim A; Gilliet M
    Rev Med Suisse; 2021 Mar; 17(732):646-652. PubMed ID: 33793103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The global impact of SARS-CoV-2 in 181 people with cystic fibrosis.
    McClenaghan E; Cosgriff R; Brownlee K; Ahern S; Burgel PR; Byrnes CA; Colombo C; Corvol H; Cheng SY; Daneau G; Elbert A; Faro A; Goss CH; Gulmans V; Gutierrez H; de Monestrol I; Jung A; Justus LN; Kashirskaya N; Marshall BC; McKone E; Middleton PG; Mondejar-Lopez P; Pastor-Vivero MD; Padoan R; Rizvi S; Ruseckaite R; Salvatore M; Stephenson AL; Filho LVRDS; Melo J; Zampoli M; Carr SB;
    J Cyst Fibros; 2020 Nov; 19(6):868-871. PubMed ID: 33183965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detectable Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Human Breast Milk of a Mildly Symptomatic Patient With Coronavirus Disease 2019 (COVID-19).
    Tam PCK; Ly KM; Kernich ML; Spurrier N; Lawrence D; Gordon DL; Tucker EC
    Clin Infect Dis; 2021 Jan; 72(1):128-130. PubMed ID: 32472683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of the combination of modern medicine and traditional Chinese medicine in pulmonary fibrosis arising as a sequelae in convalescent COVID-19 patients: a randomized multicenter trial.
    Lu ZH; Yang CL; Yang GG; Pan WX; Tian LG; Zheng JX; Lv S; Zhang SY; Zheng PY; Zhang SX
    Infect Dis Poverty; 2021 Mar; 10(1):31. PubMed ID: 33731163
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immune response in SARS-CoV-2 infection: the role of interferons type I and type III.
    Portela Sousa C; Brites C
    Braz J Infect Dis; 2020; 24(5):428-433. PubMed ID: 32866437
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Update on SARS-CoV-2 infection in children.
    Martins MM; Prata-Barbosa A; da Cunha AJLA
    Paediatr Int Child Health; 2021 Feb; 41(1):56-64. PubMed ID: 33616026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Persistence of intestinal SARS-CoV-2 infection in patients with COVID-19 leads to re-admission after pneumonia resolved.
    Wang X; Zhou Y; Jiang N; Zhou Q; Ma WL
    Int J Infect Dis; 2020 Jun; 95():433-435. PubMed ID: 32353545
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reply to: "NAFLD is a predictor of liver injury in COVID-19 hospitalized patients but not of mortality, disease severity on the presentation or progression - The debate continues".
    Ji D; Cheng G; Lau G
    J Hepatol; 2021 Feb; 74(2):484-485. PubMed ID: 33130185
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.